ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO)

CUSIP: 00289Y206

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-300,191
SEC-reported price per share
$5.25
Number of holders
21
Value change
-$1,602,082
Number of buys
12
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
57,048,574

Security key

00289Y206

Report period

Q3 2026

Institutions

21

Top holders

10

Ownership snapshot

Top reported holders of ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
8/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 10% 7 rows are not safely comparable across share classes. 13D/G row: Nantahala Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC leads the comparable SEC ownership view at 10%.

8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Nantahala Capital Management, LLC 10%
Nantahala Capital Partners Limite... 5.8%
BlackRock, Inc. 5.8%
Orin Hirschman 5.4%
Funicular Funds, LP 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13F 13D/G
Company
10%
Reported 13D/G · 31 Mar 2026
$31,743,508
5,136,490 shares
— 30 Jun 2026
Nantahala Capital Partners Limited Partnership
13D/G
5.8%
Reported 13D/G · 31 Mar 2026
$16,868,810
3,333,757 shares
+$3,619,393 31 Mar 2026
BlackRock, Inc.
13F 13D/G
Company
5.8%
Reported 13D/G · 30 Jun 2025
$20,718,290
3,352,474 shares
— 30 Jun 2026
Orin Hirschman
13D/G
5.4%
Reported 13D/G · 31 Mar 2026
$13,893,270
3,100,000 shares
$0 31 Mar 2026
Funicular Funds, LP
13D/G
5.3%
Reported 13D/G · 27 Mar 2026
$14,916,352
3,007,329 shares
$0 27 Mar 2026
Daniel Louis Kaufman
13D/G
Daniel Kaufman
5.2%
Reported 13D/G · 26 Mar 2026
$15,306,871
2,943,629 shares
$0 26 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
21
Shares
4,255,466
Rows available
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
126
Q3 2026 holders
21
Holder diff
-105
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .